Back to Stakeholders
Categories

1 domain / 1 area / 1 specialization

Care Delivery & Psychedelic Facilitation
Psychedelic Healthcare ImplementationHealth Economists

ISPOR (The Professional Society for Health Economics and Outcomes Research)

Data updated

Global HEOR professional society with major U.S. footprint and an evidence dissemination platform that includes psychedelic-adjacent esketamine budget-impact analyses.

Reimbursement & Market Access Snapshot

Health Economists

Service Model

Health Economics Research Group

Jurisdiction

Global

Coverage

Global

Last Verified

Apr 11, 2026

Focus Areas

Cost-Effectiveness ModelingBudget Impact AnalysisHTA Evidence Appraisal

Evidence Requirements

Clinical Efficacy EndpointsComparative EffectivenessCost-EffectivenessBudget Impact

Market Access Notes

ISPOR presentation resources include U.S. budget-impact work on esketamine for treatment-resistant depression, making it directly relevant for psychedelic-adjacent market-access evidence.

Verification

Verified

Psychedelic Focus

Explicit Psychedelic Focus

Engagement Status

Active

Primary Access Link

Linked Stakeholders

Institute for Clinical and Economic Review (ICER)

Source Evidence

ISPOR Presentation - Budget Impact Analysis of Esketamine in TRD in the United States

https://www.ispor.org/heor-resources/presentations-database/presentation/intl2019-1111/91902

ISPOR HEOR Resources

https://www.ispor.org/heor-resources

Quick Facts

Website
Visit